ATYR   $0.8094  -1.77% Market Open

aTyr Pharma, Inc.
Total Cash 78.48M
totalCashPerShare 1.035
EBITDA -61.82M
Total Debt 13.85M
quickRatio 6.768
currentRatio 7.628
Total Revenue 588.00K
debtToEquity 17.011
Revenue/Share 0.009
ROA -0.32744
ROE -0.61764
grossProfits
freeCashflow -40.94M
operatingCashflow -63.45M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -106.33503
profitMargins 0.0
enterpriseValue 165.61M
forwardPE -3.8481011
floatShares 68.77M
sharesOutstanding 75.80M
sharesShort 1.07M
sharesShortPriorMonth 685.78K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.70%
Short Ratio help_outline 1.15%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 1.077
Price To Book help_outline 2.82
earningsQuarterlyGrowth
netIncomeToCommon -57.90M
trailingEps -0.90%
forwardEps -0.79%
enterpriseToEbitda -2.68
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.22 3Q 2024
institutionsCount 56
lastUpdated Nov. 2, 2024, 7:40 a.m.